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Differences between the genomes of lymphoblastoid cell lines 
and blood-derived samples
Lena M Joesch-Cohen and Gustavo Glusman
Institute for Systems Biology, Seattle, WA, USA
Abstract
Lymphoblastoid cell lines (LCLs) represent a convenient research tool for expanding the amount 
of biologic material available from an individual. LCLs are commonly used as reference materials, 
most notably from the Genome in a Bottle Consortium. However, the question remains how 
faithfully LCL-derived genome assemblies represent the germline genome of the donor individual 
as compared to the genome assemblies derived from peripheral blood mononuclear cells. We 
present an in-depth comparison of a large collection of LCL- and peripheral blood mononuclear 
cell-derived genomes in terms of distributions of coverage and copy number alterations. We found 
significant differences in the depth of coverage and copy number calls, which may be driven by 
differential replication timing. Importantly, these copy number changes preferentially affect 
regions closer to genes and with higher GC content. This suggests that genomic studies based on 
LCLs may display locus-specific biases, and that conclusions based on analysis of depth of 
coverage and copy number variation may require further scrutiny.
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Introduction
Transformation of peripheral blood mononuclear cells (PBMCs) into lymphoblastoid cell 
lines (LCLs) through infection by Epstein–Barr virus is a commonly used practice for 
creating an unlimited supply of cells for use in a variety of studies. Such LCLs are used 
interchangeably with non-LCLs, often as in vitro model systems1 or as sources of genomic 
data.2,3 Notably, the “benchmark” human genomes used as references by the Genome in a 
Bottle Consortium are Epstein–Barr virus-transformed LCLs maintained by the Coriell 
Institute.4,5
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Although genomic data from LCLs are often used as a bona fide source of genomic data, 
investigation is still underway to confidently conclude whether LCLs provide a faithful copy 
of their donor genome. A number of studies have examined differences between LCLs and 
their donors using a variety of metrics. Studies involving large cohorts of LCLs and controls 
have investigated mutations in mitochondrial DNA (mtDNA) through the analysis of whole-
exome data6 and gene expression analysis,7 as well as variation in genotype and copy 
number variations (CNVs) throughout the genome.8 Studies performed on single pairs or 
small groups (n≤20) of blood-derived genomes and their directly derived LCLs have 
compared CNV calls between LCLs and controls, using both array comparative genomic 
hybridization and whole genome data.9,10 Other studies have investigated differences in 
single nucleotide polymorphisms (SNPs) and other variations, using both SNP arrays and 
exome data,11,12 as well as methylation profiles and gene expression levels.13,14
We present an in-depth comparison of a large collection of LCL-derived genomes with 
matched PBMC-derived genomes based on distributions of coverage and copy number 
alterations. We found significant locus-specific differences in the depth of coverage and 
copy number calls, which may be driven by differential replication timing.
Materials and methods
Description of data sets
Drawing from whole-genome assemblies that had been created for previous studies between 
September 2010 and February 2014, we compiled a set of 126 assemblies (63 males, 63 
females) derived from LCLs, sequenced at high quality (>40 × average coverage) by 
Complete Genomics, Inc. (CGI) and analyzed using human genome freeze GRCh37 (hg19) 
as reference. We then created two “matched control” sets (MC1 and MC2), composed of 
nonoverlapping sets of 126 blood-derived whole-genome assemblies. The genomes in these 
sets were individually matched to the 126 LCLs by metadata. Matching requirements 
included being of the same sex, having been sequenced on the same platform (CGI), mapped 
to the same reference genome (GRCh37) and analyzed using the same Complete Genomics 
Analysis Pipeline software version (Table 1).15 Most genome assemblies are of European 
descent; the distribution of populations at continental region resolution shows slightly less 
diversity in the LCL than control sets (Table 2).
Analysis of normalized coverage profiles
For each genome, we computed its normalized coverage profile as described.16 This profile 
reports the normalized coverage level at 1 kb bins along the genome; a value of 100 
represents the expected diploid coverage. From these coverage levels, we computed for each 
genome several summary statistics of normalized coverage, namely, the standard deviation, 
median and median absolute deviation (MAD). We also computed these statistics for each 
chromosome, including mtDNA. We combined normalized coverage profiles for each set 
(LCLs, MC1 and MC2) to calculate the average genome span at each coverage level across 
all assemblies. We then visualized these distributions, along with their standard deviation 
around the average coverage, to compare the three sets of genomes.
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Analysis of reference coverage profiles
For each set of genome assemblies, we computed reference coverage profiles (RCPs) as 
described.16 This yielded the reference coverage (i.e., the coverage value corresponding to 
diploid coverage), prenormalized median coverage, the MAD around the prenormalized 
median coverage, and the distribution of prenormalized coverage levels for every 1 kb bin 
along the genome. We used RCPs to compare the three sets of assemblies in pairwise 
fashion (namely, LCL vs MC1, LCL vs MC2, MC1 vs MC2). For each comparison, we 
computed a two-sample Kolmogorov–Smirnov (KS) statistic on the coverage level 
distributions in each set of bins. The KS statistic ranges from 0 to 1, which represent an 
exact match or no overlap between the two distributions, respectively. For each of the three 
comparisons, we then visualized the reported KS statistic along each chromosome, 
smoothing over 1 Mb (1000 consecutive bins). To compare the KS values with the GC 
content, we subdivided the genome into 25 “GC buckets” of similar size and increasing GC 
percentiles, as described.16 We computed distances to the nearest exons and segmental 
duplication level as annotated in the knownGene and genomicSuperDups tracks from the 
University of California, Santa Cruz database, respectively.17 We evaluated the relationship 
with replication timing ratio as observed in the C0202 LCL (GEO: GSM500943).18,19 We 
also used RCPs to investigate the coverage level distributions across the three sets in 
individual bins.
Analysis of CNV calls
For each genome, we computed CNVs as described.16 Each CNV call is characterized by its 
observed ploidy level (denoted by integer values between 0 and 4, where 4 represents 
genomic regions with four or more copies), its location in the genome and its frequency in a 
reference population. For each genome, we selected rare CNV calls (with population 
frequency ≤1%) and visualized the distribution of rare CNV counts across all 126 
assemblies in each set, grouping the CNVs by ploidy level.
Results
The autosomal coverage distribution of LCLs differs from that of PBMCs
The uncorrected depth of sequencing coverage can fluctuate significantly within each 
genome, but becomes very uniform by normalization using RCPs.16 Successfully 
normalized autosomal coverage follows a narrow distribution, centered on 100% of the 
expected diploid coverage; the width of this distribution serves as a metric of uniformity of 
genome coverage.
We compared the averaged distribution of normalized autosomal coverage in three sets of 
genomes: one consisting of genomes from LCLs and two of matched controls from PBMCs. 
We observed higher variability of coverage levels in LCLs than in the controls (Figure 1): 
average coverage counts close to the expected value of 100% (95%–104%) were higher in 
the controls, whereas average counts farther out from 100% (extending to 80% and 120%) 
were higher in LCLs. Standard distributions of coverage around average levels show that 
while there is overlap in average coverage between the LCLs and controls, the two groups 
are nonetheless distinct (Figure 1, inset).
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Inspection of standard deviations of normalized coverage on a per assembly basis showed 
that the trend of wider normalized coverage distributions is more evident in some pipeline 
software versions than in others (Figure 2): more recent versions of the pipeline tend to 
exhibit larger standard deviation (wider distribution of normalized coverage) in LCLs than in 
PBMCs. This trend is particularly evident starting from version 2.0.3.2: in it and later 
pipeline versions, most LCLs exhibit less uniform normalized coverage than their matched 
controls.
The magnitude of this trend is not distributed evenly among the chromosomes. We observed 
a larger difference in normalized coverage variation between LCLs and controls in 
chromosomes 12 and 14, but almost no difference in chromosome 19 (Figure 3).
The mitochondrial coverage of LCLs differs from that of PBMCs
We also observed a much larger difference in coverage between LCLs and controls in 
mtDNA. Most notably, the median average coverage level in mtDNA in LCLs is almost 
fourfold higher than in the controls, with some increases in mtDNA in LCLs up to 12-fold. 
This finding is consistent with previous studies, which have reported increases of up to 
ninefold in mtDNA in LCLs.7,10 As in autosomes, the distribution of coverage levels in 
mtDNA is significantly wider in LCLs than in controls. We observed, on average, a standard 
deviation and MAD of 20.0 and 20.1, 4.1 and 3.5 and 3.7 and 3.1 in LCLs, MC1 and MC2, 
respectively.
Considering the expanded mtDNA coverage in LCLs, we hypothesized a potential 
mismapping effect on autosomes, due to the presence of nuclear mtDNA segments.20 We 
found a very slight increase in coverage deviation in autosomes with higher nuclear mtDNA 
segment content, but these are not sufficient to account for the large observed differences 
between LCLs and controls, and among autosomes.
LCL coverage fluctuates along the chromosomes
To explore the differences in coverage at higher resolution, we performed bin-by-bin 
comparisons of coverage level distributions using the KS statistic. The results of this 
analysis show that distributions vary much more between LCLs and controls than between 
the two sets of controls on a per-bin basis, consistent with our observations on a per-
chromosome level. KS statistics comparing LCLs and controls range from 0 to ~0.9, with a 
median of 0.266 and a MAD of 0.153. KS values comparing the two controls, however, 
range only from 0 to ~0.3, with a median of 0.079 and a MAD of 0.024.
We next visualized the KS statistic along each chromosome and found that the variation 
between LCLs and controls is present in all autosomes and throughout the length of each 
chromosome. However, there are strong regional fluctuations in KS values (Figure 4). 
Examining these regions showed that lower KS values for LCLs vs controls correspond to 
similar coverage distributions across all three sets, whereas larger KS values show different 
coverage distributions between LCLs and controls (Figure 4B). This difference typically 
represents increased coverage in LCLs relative to controls.
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The fluctuation of KS values along the chromosomes approximately correlates with 
chromosomal banding (Figure 4A): LCLs tend to have more distorted coverage in light 
bands (Giemsa negative, or R bands) relative to controls, but more similar coverage in dark 
bands (Giemsa positive or G bands). Giemsa banding patterns are related to both GC content 
and gene density, as well as replication stage, with R bands replicating early.21 We observed 
that KS values are weakly correlated with GC content and gene presence, with median KS 
value rising with increasing GC percentile (Figure 5A) and decreasing with increasing 
distance from the nearest exon (Figure 5B). We observed a much stronger relationship with 
replication timing ratio:18 most of the coverage difference between LCLs and controls is 
located in early-replicating regions of the genome as previously reported in the C0202 
LCL;19 the earlier the replication timing, the stronger the difference (Figure 5C). The 
differences between LCLs and controls were not enriched in segmentally duplicated regions 
of the genome (Figure 5D).
We demonstrate this coverage distortion by example, by comparing one LCL (pipeline 
version 2.4.0.43) and its matched controls in the early-replicating chromosomal band 2p22.2 
(Figure 6). We observe 5%–10% excess coverage in the LCL over a span of almost 1 Mb, 
with finer-scale excess coverage frequently in the 20%–30% range.
LCLs display modified CNV counts
Distortions in depth of coverage can lead to changes in the inferred ploidy levels, both at 
known CNV regions and in typically copy-invariant loci. We evaluated the distribution of 
number of rare CNV calls (frequency ≤1% in a reference population) in the genomes of 
LCLs and their matched controls. We observed in LCLs (relative to controls) an increase in 
the number of segments with ploidy levels 0, 1 and 4 (null, haploid and tetraploid or greater, 
respectively); we observed no change for ploidy level 3 (Figure 7).
A previous study reported high similarity of CNV counts in LCL- and PBMC-derived 
genomes, though results were based only on a small sample.8 Likewise, another study 
reported only four regions in which an LCL had a different copy number from its “donor” 
genome.10 This second study included only two genome assemblies, constructed using an 
old version (1.10.0.22) of the CGI pipeline software. We found that early pipeline versions 
have less ability to observe differences in coverage (Figure 2); most of our comparisons 
involve genome assemblies constructed using CGI pipeline software versions 2.0.2.22 
through 2.5.0.20.
Discussion
We compared genome-wide patterns of depth of coverage (after normalization using RCPs) 
of LCL- and PBMC-derived genomes. While PBMCs represent the actual somatic genome 
as derived from direct tissue (blood) samples, LCLs are immortalized using viral 
transformation; their genomes are expected to be different from the “donor” genomes in a 
number of ways. We indeed found differences: LCLs have a broader distribution of coverage 
(after normalization; Figure 1); the differences display a nontrivial pattern along the 
chromosomes (Figure 4), including higher copy number of the mitochondrial chromosome; 
LCLs have regions with deeper coverage than PBMCs (Figure 4B); changes in coverage are 
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not enriched in segmentally duplicated regions, but they are somewhat correlated with the 
GC content and gene density, and are even more strongly correlated with replication timing 
(Figure 5). These regional differences in coverage (Figure 6) can lead to differences in CNV 
calls (Figure 7).
Several prior studies have compared LCLs to their donor genomes using techniques such as 
SNP typing and gene expression analysis, and have found, for the most part, only minor 
notable differences in coverage. Using SNP arrays, one study reported a high SNP 
concordance between early-passage LCLs and controls, but suggested that loss of 
heterozygosity may explain genotype discordance in late-passage LCLs.12 Another study 
reported high concordance rates between genotypes and copy number in LCLs and 
controls.8 More recent studies have also used whole-exome and whole-genome sequences, 
but have also reported only minimal differences in coverage between LCL- and PBMC-
derived genomes.10,11 Differences were found, however, in coverage levels of mtDNA. 
Researchers reported a copy number increase in LCLs in 1p36.33 and attributed this increase 
to higher levels of mtDNA.9 Other findings also suggested a higher level of mtDNA, as well 
as mitochondria-related gene expression in LCLs.7 Two features of our study may have 
contributed to detecting previously unreported differences: the larger sample size and the 
improved normalization using RCPs. While our study design (driven by sample availability) 
did not allow us to compare LCL and PBMC genomes from the same individuals, we strove 
to effectively match our LCLs and controls by metadata to avoid batch effects and inherent 
population biases. Importantly, the set of LCLs in our study is slightly less diverse than the 
sets of controls; nevertheless, the coverage comparisons between the two sets of controls 
showed more similarity than to the set of LCLs. We conclude that the genomic differences 
displayed by LCLs are not related to population structure.
Since LCLs are actively replicating cells, differential timing of replication can reasonably be 
expected to lead to different observed coverage levels between early- and late-replicating 
regions of the genome. Indeed, the differences we observed between LCLs and PBMCs were 
concentrated in early-replicating regions of the genome. This is consistent with the cell 
division states of the LCLs, namely, a higher proportion of cells during or after S phase. We 
also observed an increase in CNV calls (Figure 7), particularly for tetraploid state, which is 
consistent with regional duplication due to early replication. The increase in CNV calls for 
haploid and null states may reflect events of DNA loss, many of which would be tolerated in 
a cell line growing in vitro. This result is consistent with the findings of previous studies, 
which suggest that earlier replicating regions of the genome are more likely to contain 
actively transcribed genes than later replicating regions.22 In turn, these actively transcribed 
regions have been shown to harbor a higher percentage of indel and substitution mutations,23 
as well as CNVs caused by nonallelic homologous recombination.24 The process of 
nonallelic homologous recombination is related to the process of homologous 
recombination, which has also been shown to preferentially occur in transcriptionally active 
chromatin, following a double-stranded break.25 The elevated level of recombination in 
early-replicating regions of the genome may thus contribute to the differential coverage 
observed in these regions.
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CNVs have been found to play a significant role in causing human disease, especially when 
CNVs occur in gene-rich areas.26 Genome-wide association studies, formerly analyzing only 
SNPs, are now being used to identify de novo and rare CNVs and to associate those CNVs 
with diseases.27 Results of such studies have already shown de novo CNVs to be causal 
factors in both autism and schizophrenia. As such, the accurate identification and analysis of 
CNVs become vitally important in the clinic, especially in prenatal settings, in which the 
discovery of disease-causing CNVs can help to shape care and management of such 
diseases.26
In summary, and in contrast with previous reports, we observed significant differences in the 
depth of coverage between LCL- and PBMC-derived genome assemblies, leading to 
differential CNV calls. Importantly, these copy number changes preferentially affect regions 
with higher GC content and closer to genes. This suggests that genomic studies based on 
LCLs may display locus-specific biases, and that conclusions based on depth of coverage 
analysis and copy number considerations may require further scrutiny.
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Notes: LCLs display a wider distribution of average normalized coverages than matched 
controls (MC1 and MC2). Inset: standard deviations around the average coverage in the 
90%–110% range.
Abbreviations: LCL, lymphoblastoid cell line; MC1 and MC2, matched control sets 1 and 
2.
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Notes: Newer software versions have better ability to separate LCLs (blue) from matched 
controls (MC1 and MC2) by standard deviation of normalized coverage. Genome assemblies 
are arranged by assembly software version and chronologically.
Abbreviations: LCL, lymphoblastoid cell line; MC1 and MC2, matched control sets 1 and 
2.
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Chromosomal distribution of coverage deviations.
Notes: All autosomes except for chr19 display higher coverage variability (standard 
deviation of normalized coverage) in LCLs as compared to the control sets.
Abbreviations: LCLs, lymphoblastoid cell lines; MC1 and MC2, matched control sets 1 and 
2.
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Genome set comparison along chromosomes.
Notes: (A) Smoothed KS statistic values (smoothing width=1000 bins=1 Mb) comparing 
LCLs to MC1 (blue), LCLs to MC2 (purple) and MC1 to MC2 (red) mapped along 
chromosomes 9 and 15; the inset chromosome ideograms show the increased KS values 
between LCLs and controls in early-replicating, light Giemsa bands. (B) Similar 
comparisons for chr6, highlighting regions of high dissimilarity between the normalized 
coverage distributions of LCLs and controls (lower left) and of similarity between all sets 
(lower right). Blue, red and green denote LCLs, MC1 and MC2, respectively.
Abbreviations: KS, Kolmogorov–Smirnov; LCLs, lymphoblastoid cell lines; MC, matched 
controls.
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Correlation with various genomic parameters.
Notes: (A) Distribution of KS values grouped into 25 “GC buckets” (percentiles) of 
increasing GC percentage. (B) Distribution of KS values grouped by increasing distance to 
the nearest exon (square root scale). (C) Distribution of KS values grouped by replication 
timing ratio, log2 (early/late). Lower values = late replication; higher values = early 
replication. (D) Distribution of KS values grouped by segmental duplication level, from 0 
(outside segmental duplications, 94% of the genome) to 20 or more paralogous copies. The 
dashed line highlights the median KS value for the regions outside segmental duplications.
Abbreviations: KS, Kolmogorov–Smirnov.
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Example of regional coverage distortion.
Notes: Normalized coverage trace for one LCL (blue) vs its matched controls (red and 
green) in the 2p22.2 early-replicating band, averaged in overlapping 25 kb windows (upper 
panel). Blue points represent the actual 1 kb resolution normalized coverages for the LCL. 
Vertical lines connect to the transcription start sites of the known genes in this region (lower 
panel).
Abbreviations: LCLs, lymphoblastoid cell lines; MC, matched controls.
Joesch-Cohen and Glusman Page 14














Effect on copy number calls.
Notes: Distribution of rare (frequency <1%) CNV counts in LCLs (blue) and controls (red 
and green), stratified by ploidy (0 to 4+ fold).
Abbreviations: CNV, copy number variant; LCLs, lymphoblastoid cell lines; MC, matched 
controls.
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Table 1
Pipeline software versions used
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Table 2
Population distribution in the three sets of genome assemblies
Region LCLs MC1 MC2
EUR 125 117 112
AMR 1 8 12
EAS 1 1
SAS 1
Abbreviations: AMR, admixed American; EAS, East Asian; EUR, European; LCLs, lymphoblastoid cell lines; MC1 and MC2, matched control 
sets 1 and 2; SAS, South Asian.
Adv Genomics Genet. Author manuscript; available in PMC 2017 July 21.
